Eye Disease News and Research

RSS

Eye diseases are widespread around the globe. According to the World Health Organization, the most important three eye diseases or conditions that are a potential threat to the global population are diabetic retinopathy, glaucoma, and age-related macular degeneration. One more vital reason for visual harm is refractive errors. Some of the important reasons for vision loss or low vision are age, healthcare, gender, genetic problems and the prevalence of family history.

Mutations in newly discovered gene, NPHP5 cause Senior-Loken syndrome

Scientists at the University of Michigan Medical School have discovered a gene called NPHP5 and found mutations in this gene that cause a rare genetic disease called Senior-Loken syndrome. Children with this syndrome develop a type of cystic kidney disease called nephronophthisis, as well as a form of blindness called retinitis pigmentosa.

3 Mar 2005

Oak Ridge technology used to understand semiconductor defects helps people at risk of becoming blind

Millions of people at risk of becoming blind could one day be helped by an Oak Ridge National Laboratory technology originally intended to understand semiconductor defects.

10 Feb 2005

Herpes virus is everywhere and it's unavoidable

While not the first, the researchers report that this study uses the most sensitive techniques in a cross-sectional assessment performed to date of the presence of HSV-1 DNA in the eyes and mouths of healthy individuals, in terms of population size and total samples collected.

6 Jan 2005

Pegaptanib (Macugen) is an effective treatment for neovascular age-related macular degeneration

Results from two concurrent, prospective, double-blind, multi-center clinical trials show that pegaptanib (Macugen), an anti-vascular endothelial growth factor therapy, is an effective treatment for neovascular age-related macular degeneration (AMD), according to a paper in the Dec. 30 issue of the New England Journal of Medicine. Macugen was approved by the Food and Drug Administration on Dec. 17.

30 Dec 2004

Macugen approved for the treatment of neovascular (wet) age-related macular degeneration (AMD)

Eyetech Pharmaceuticals and Pfizer have announced that the U.S. Food and Drug Administration (FDA) approved Macugen (pegaptanib sodium injection) for the treatment of neovascular (wet) age-related macular degeneration (AMD), an eye disease associated with aging that destroys central vision.

20 Dec 2004

Spinach can help prevent cataracts

A new study from Ohio State University provides the first laboratory evidence that certain antioxidants found in dark leafy green vegetables can indeed help prevent cataracts.

3 Dec 2004

Computer use may be linked to the development of glaucoma

So, you spend all or part of your day working with computers. Then take notice, a new Japanese study has found that computer use may be linked to the development of glaucoma (an increase in fluid pressure inside the eye that may lead to loss of vision), especially among those who are short sighted.

16 Nov 2004

Patients with type 2 diabetes and hypertension who kept their blood pressure very tightly controlled had fewer eye disorders caused by their diabetes

According to the article, type 2 diabetes and hypertension are often associated. At age 40, approximately 32 percent of patients with type 2 diabetes are also hypertensive, and that proportion increases to 47 percent by age 60, the article states.

8 Nov 2004

Scientists have found that a protein present in normal body tissues can prevent tumour growth

A team led by Dr Dave Bates, British Heart Foundation Lecturer, and Dr Steve Harper, Senior Research Fellow in the Microvascular Research Laboratories, in the Department of Physiology at Bristol University, have discovered that a type of vascular endothelial growth factor (VEGF) found in normal tissue, including blood, can prevent cancers from growing.

1 Nov 2004

Possible new way to treat amblyopia (lazy eye)

New research suggests a way to treat "lazy eye" that may be easier on children - and their parents - than current treatments.

1 Nov 2004

Discovery of new method for visual impairment treatment

The patients suffering from visual impairment can be helped if a healthy donor’s cerebrospinal fluid is introduced to the parent’s vertebral canal – this method is called liquortransfusion.

1 Nov 2004

Drug-loaded contact lenses to treat eye diseases

When a person suffers from eye ailments today, nine times out of ten, he will be prescribed eye drops to treat his illness or relieve his discomfort.

29 Oct 2004

Fetal tissue restores lost sight from retinitis pigmentosa

Three years ago Elisabeth Bryant believed she would be blind for the rest of her life. "I couldn't see anything," she says. Now, although her vision is not perfect, she can see well enough to read, play computer games and check emails.

28 Oct 2004

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Eli Lilly and Company's investigational compound ruboxistaurin may reduce vision loss from diabetes-induced eye disease, according to new analyses of previously reported data presented at the 2004 Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology in New Orleans, La.

26 Oct 2004

Transplanted human retinal stem cells can successfully regenerate

"We transplanted the cells early in the animals' development when all the nutrients and signals they needed for differentiation were still there," says lead author Brenda Coles, a U of T laboratory technician working under the supervision of Professor Derek van der Kooy in the Department of Medical Genetics and Microbiology. "When their eyes fully developed, the human cells survived, migrated into the sensory part of the eye and formed the correct cells."

25 Oct 2004

Collaborative research will help bring hope to Americans who are losing their sight to degenerative retinal diseases

A collaborative research and development agreement signed today between the U.S. Department of Energy (DOE) and Second Sight LLC will help bring hope to hundreds of thousands of Americans who are losing their sight to degenerative retinal diseases.

18 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Eye Disease News and Research

Further Reading

Mutations in newly discovered gene, NPHP5 cause Senior-Loken syndrome

Oak Ridge technology used to understand semiconductor defects helps people at risk of becoming blind

Herpes virus is everywhere and it's unavoidable

Pegaptanib (Macugen) is an effective treatment for neovascular age-related macular degeneration

Macugen approved for the treatment of neovascular (wet) age-related macular degeneration (AMD)

Spinach can help prevent cataracts

Computer use may be linked to the development of glaucoma

Patients with type 2 diabetes and hypertension who kept their blood pressure very tightly controlled had fewer eye disorders caused by their diabetes

Scientists have found that a protein present in normal body tissues can prevent tumour growth

Possible new way to treat amblyopia (lazy eye)

Discovery of new method for visual impairment treatment

Drug-loaded contact lenses to treat eye diseases

Fetal tissue restores lost sight from retinitis pigmentosa

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Transplanted human retinal stem cells can successfully regenerate

Collaborative research will help bring hope to Americans who are losing their sight to degenerative retinal diseases

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

The same gene functions in vision and immune system, research shows

Potential stem cells treatment for retinitis pigmentosa and other retinal degenerations

Treatment with vitamin A and an omega-3 fatty acid slows down the progression of retinitis pigmentosa

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News